| |
-I.V. Catheter Tip
-I.V. Tubing Culture
-ICSH
-Ictotest for Bilirubin
-IEP
-IEP/IFE Profile, Comprehensive (IEP)
-IEP/IFE Profile, Serum (SIEPB)
-IEP/IFE Profile, Urine (UIEPB)
-IFE
-IgA
-IgA Fibronectin Aggregates (IAFAP)
-IgA Subclasses
-IgE
-IGF Binding Protein
-IGF-1 (IGF)
-IGF-1
-IGFBP3
-IgG
-IgG Subclasses
-IgG/A/M
-IgG/A/M/E
-IgM
-IgM Antibody (TOXM )
-Imipramine (IMIPR)
-ImmuKnow (ICFA)
-Immune Complex C1q Binding Assay (IC1Q)
-Immune Complex C3b Binding Assay (CSIC)
-Immunoelectrophoresis
-Immunoelectrophoresis Profile, Serum
-Immunoelectrophoresis Profile, Urine
-Immunoglobulin (MIGM)
-Immunoglobulin A (IGA)
-Immunoglobulin A Subclasses (IGASB)
-Immunoglobulin D (IGD)
-Immunoglobulin E, Total (IGE)
-Immunoglobulin G Subclasses (IGGS)
-Immunoglobulin G/A/M
-Immunoglobulin Profile 1 (IGAM)
-Immunoglobulin Profile 2 (IGAME)
-ImmunoglobulinG (IGG)
-Immunohistochemistry
-Inderal®
-India Ink Preparation (INK)
-Indican, Urine (INDC)
-Indirect Anti-Human Globulin Test
-Indirect Antiglobulin Test
-Indirect Coombs
-Infectious Mononucleosis Screening Test
-Influenza A/B Antibody Profile (INFPP)
-Influenza A/B Screen, Rapid (FLUAB)
|
|
|
|
Print |
| Isoenzymes Profile CKMB Isoenzymes |
| |
| See Creatine Phosphokinase Isoenzymes Profile |
Print |
| ICSH |
| |
| See Luteinizing Hormone, Serum |
Print |
| Ictotest for Bilirubin |
| |
| See Bilirubin, Urine |
Print |
| IEP |
| |
| See IEP/IFE Profile, Comprehensive |
Print |
| IEP/IFE Profile, Comprehensive |
| |
| Includes: |
•Immunoglobulins IgG, IgA, IgM •Protein Electrophoresis, Serum (SPEP) •Immunofixation Electrophoresis, Serum (IFE) •Protein Electrophoresis, Urine (UPEP) •Immunofixation Electrophoresis, Urine (IFE) •Scans and pathologist’s interpretive report |
| |
| CPT: |
82784 (x3), 84165, 86334 84155, 8416), 86335 |
| |
| Alternate Name: |
IEP; IFE; Immunoelectrophoresis; Qualitative Immunoglobulins |
| |
| Methodology: |
See individual test listings |
| |
| Testing Schedule: |
Routine, 3 times per week |
| |
| Report Available: |
5-7 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
3 mL serum AND 20-40 mL urine |
| |
| Container: |
Gold top (serum separator) tube AND plastic urine container |
| |
| Collection: |
Freshly voided random urine, preferably firstmorning specimen OR an aliquot of a well-mixed 24-Hour urine collection containing no preservative |
| |
| Special Instructions and/or Comments: |
| Refrigerate |
| |
| Reference Range: |
| See individual test listings. |
| |
| Clinical Utility: |
| Evaluate serum protein, nutritional status; work up liver disease, including chronic active hepatitis; useful in evalutaion of myeloma, macroglobulinemia of Waldenstrom, monoclonal gammopathies and amyloidosis; evaluate inflammatory states and collagen-vascular disorders; evaluate low back pain, arthritis;evaluate lymphoma, leukemia, anemia. |
| |
Print |
| IEP/IFE Profile, Serum |
| |
| Includes: |
•Immunoglobulins IgG, IgA, IgM •Protein Electrophoresis, Serum (SPEP) •Immunofixation Electrophoresis, Serum (IFE) •Scans and pathologist’s interpretive report |
| |
| CPT: |
82784 (x3), 84155, 84165, 86334 |
| |
| Alternate Name: |
Immunoelectrophoresis Profile, Serum; Serum Immunoelectrophoresis; SIEP |
| |
| Methodology: |
See individual test listings. |
| |
| Testing Schedule: |
3 times per week |
| |
| Report Available: |
5-7 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
3 mL serum |
| |
| Container: |
Gold top (serum separator) tube |
| |
| Reference Range: |
| See individual test listings. |
| |
| Clinical Utility: |
| The presence of a paraprotein is suggestive of multiple myeloma, primary amyloidosis, benign monoclonalgammopathies (monoclonal gammopathies of undetermined significance [MGUS]), Waldenström macroglobulinemia or other lymphoproliferative disease. A paraprotein can be present even when total serum protein, beta and gamma globulin, and quantitative immunoglobulin concentrations are all within normal ranges. |
| |
Print |
| IEP/IFE Profile, Urine |
| |
| Includes: |
•Protein Electrophoresis, Urine (UPEP) •Immunofixation Electrophoresis, Urine (IFE) •Scans and pathologist’s interpretive report |
| |
| CPT: |
84166, 86335 |
| |
| Alternate Name: |
Immunoelectrophoresis Panel, Urine; UIEP; Urine Immunoelectrophoresis |
| |
| Methodology: |
See individual test listings. |
| |
| Testing Schedule: |
Routine, 3 times per week |
| |
| Report Available: |
5-7 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
20-40 mL urine |
| |
| Container: |
Plastic urine container |
| |
| Collection: |
Freshly voided random urine, preferably first morning specimen OR an aliquot of a well-mixed 24-Hour urine collection containing no preservative |
| |
| Special Instructions and/or Comments: |
| Refrigerate |
| |
| Reference Range: |
| See individual test listings. |
| |
| Clinical Utility: |
| Useful in characterizing the species of protein or proteins in cases of proteinuria. Agarose gel immunofixation electrophoresis (IFE) can identify albumin, gamma globulin, gamma globulin fragments (light chains Bence Jones proteins). Of value in the study of monoclonal gammopathies, lymphoproliferative diseases, including lymphoma; special application to multiple myeloma, macroglobulinemia of Waldenstrom and amyloidosis. Monoclonal gammopathy (M spike) work-up. |
| |
Print |
| IFE |
| |
| See IEP/IFE Profile, Comprehensive |
Print |
| IgA |
| |
| See Immunoglobulin A |
Print |
| IgA Fibronectin Aggregates |
| |
| CPT: |
83516 |
| |
| Methodology: |
Enzyme-Linked Immunosorbent Assay (ELISA) |
| |
| Testing Schedule: |
Routine, 1 time per week |
| |
| Report Available: |
7-10 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum Container: Gold top (serum separator) tube |
| |
| Special Instructions and/or Comments: |
| Refrigerate |
| |
| Reference Range: |
| <3.0 EIA Units =Aggregates Not Detected |
| |
| Clinical Utility: |
| Aggregates consisting of IgA complexed with fibronectin are found in sera of most patients with IgAnephropathy and patients with Henoch-Schonleinpurpura. Detection of these aggregates is based on their specific attachment to a fragment of Type I collagen. |
| |
Print |
| IgA Subclasses |
| |
| See Immunoglobulin A SubclassesIgD |
| See Immunoglobulin D |
Print |
| IgE |
| |
| See Immunoglobulin E, Total |
Print |
| IGF-1 |
| |
| CPT: |
84305 |
| |
| Alternate Name: |
• Insulin Growth Factor 1 • Somatomedin C |
| |
| Methodology: |
Enzyme labeled chemiluminescence |
| |
| Testing Schedule: |
Routine, Monday - Friday |
| |
| Report Available: |
3-5 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum |
| |
| Container: |
1 Gold top (SST) tube |
| |
| Special Instructions and/or Comments: |
| Refrigerate |
| |
| Reference Range: |
| Age related reference values accompany report |
| |
| Clinical Utility: |
Useful for: Diagnosing growth disorders Diagnosing adult growth hormone deficiency Monitoring of rhGH treatment Laboratory monitoring of nutritional status |
| |
Print |
| IGF-1 |
| |
| See Insulin-Like Growth Factor-1 |
Print |
| IGF Binding Protein |
| |
| See Insulin Like Growth Factor BP3 |
Print |
| IGFBP3 |
| |
| See Insulin Like Growth Factor BP3 |
Print |
| IgG |
| |
| See Immunoglobulin G |
Print |
| IgG/A/M |
| |
| See Immunoglobulin Profile 1 |
Print |
| IgG/A/M/E |
| |
| See Immunoglobulin Profile 2 |
Print |
| IgG Subclasses |
| |
| See Immunoglobulin G Subclasses |
Print |
| IgM |
| |
| See Immunoglobulin M |
Print |
| IgM Antibody |
| |
| Includes: |
Toxoplasma IgM Antibody for evaluation of current or recent infection. |
| |
| CPT: |
86778 |
| |
| Alternate Name: |
T. gondii Antibody IgM; Toxo IgM |
| |
| Methodology: |
IgM Capture Enzyme-Linked Immunosorbent Assay (ELISA) |
| |
| Testing Schedule: |
Routine, 2 times per week |
| |
| Report Available: |
5-7 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum |
| |
| Container: |
Gold top (serum separator) tube |
| |
| Reference Range: |
| Negative no antibody detected. |
| |
| Clinical Utility: |
| Support the serodiagnosis of toxoplasmosis. |
| |
Print |
| Imipramine |
| |
| Includes: |
•Imipramine + Desipramine •Desipramine only |
| |
| CPT: |
80174, 80160 |
| |
| Alternate Name: |
Tofranil® |
| |
| Methodology: |
High Performance Liquid Chromatography (HPLC) |
| |
| Testing Schedule: |
Routine, Monday-Friday only |
| |
| Report Available: |
3-5 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
3 mL EDTA plasma |
| |
| Container: |
Lavender top (EDTA) tube |
| |
| Collection: |
Collect 12 hours after last dose. |
| |
| Special Instructions and/or Comments: |
| Refrigerate |
| |
| Reference Range: |
Imipramine + Desipramine: •Total Therapeutic:.................125-275 ng/mL •Total Toxic:.........................>500 ng/mL Desipramine only: •Total Therapeutic:.................75-225 ng/mL |
| |
| Clinical Utility: |
Useful for, assessing optimal therapeutic levels Assessing potential toxicity. |
| |
Print |
| ImmuKnow |
| |
| CPT: |
86352 |
| |
| Alternate Name: |
• Cylex Immuno Tcell Assay • Immune Cell Function Assay |
| |
| Methodology: |
The assay combines cell stimulation, cell selection, and quantification of the metebolic marker ATP to measure cell mediated immunily |
| |
| Specimen Requirements: |
| Minimum Volume: |
3 mL whole blood |
| |
| Container: |
Green top (sodium heparin) |
| |
| Special Instructions and/or Comments: |
• Collect Monday-Friday ONLY, No HOLIDAYS • Specimens must arrive in the laboratory no later than 1600 • Store as whole blood in original tuve at room temperature • DO NOT centrifuge, aluquot, refrigerate or freeze |
| |
| Reference Range: |
Low Immune Response............<225 ATP level ng/mL Moderate Immune Response:...226-524 ATP level ng/mL Strong Immune Response:........>525 ATP level ng/mL |
| |
| Clinical Utility: |
| Useful for detecting cell mediated immunity in an immunosuppressed population |
| |
Print |
| Immune Complex C1q Binding Assay |
| |
| CPT: |
86332 |
| |
| Methodology: |
Enzyme-Linked Immunosorbent Assay (ELISA) |
| |
| Testing Schedule: |
Routine, 1 time per week |
| |
| Report Available: |
7-10 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum |
| |
| Container: |
Red top no serum separator tube |
| |
| Special Instructions and/or Comments: |
•Transport to the laboratory immediately. •Must be processed and frozen immediately. •Centrifuge, transfer to plastic aliquot tube and freeze.Once frozen, transport specimen submergedin dry ice. |
| |
| Reference Range: |
<4.4mcg/mL EQ: Negative 4.4-10.7 mcg/mLEQ: Equivocal > 10.8 mcg/mL EQ: Positive |
| |
| Clinical Utility: |
| Assay detects circulating immune complexes which are capable of activating the classical complement pathway. |
| |
Print |
| Immune Complex C3b Binding Assay |
| |
| CPT: |
86332 |
| |
| Alternate Name: |
Raji Cell Assay |
| |
| Methodology: |
Enzyme Immunoassay (EIA) |
| |
| Testing Schedule: |
Routine, 1 time per week |
| |
| Report Available: |
7-10 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL plasma |
| |
| Container: |
Lavender top (EDTA) tube NOTE: 1 mL serum from Gold top (SST) is also acceptable |
| |
| Special Instructions and/or Comments: |
•Transport to the laboratory immediately. •Must be processed and frozen immediately. •Centrifuge, transfer to plastic aliquot tube andfreeze.Once frozen, transport specimen submergedin dry ice. |
| |
| Reference Range: |
< 15 µg Eq/mL |
| |
| Clinical Utility: |
| Detects circulating immune complexes (CIC) with C3deposited on the complex |
| |
Print |
| Immunoelectrophoresis |
| |
| See IEP/IFE Profile, Comprehensive |
Print |
| Immunoelectrophoresis Profile, Serum |
| |
| See IEP/IFE Profile, Serum |
Print |
| Immunoelectrophoresis Profile, Urine |
| |
| See IEP/IFE Profile, Urine |
Print |
| Immunoglobulin A |
| |
| Alternate Name: |
IgA; Quantitative IgA |
| |
| Methodology: |
Rate Nephelometry |
| |
| Testing Schedule: |
Routine, 4 times per week |
| |
| Report Available: |
1-3 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
•Pediatric:......................0.4 mL serum •Adults:..........................1 mL serum |
| |
| Container: |
Gold top (serum separator) tube OR 2 yellow or redBD Microtainer™ tubes |
| |
| Reference Range: |
0-1 year:..................................0-83 mg/dL 1-3 years:................................20-100 mg/dL 4-6 years:................................27-195 mg/dL 7-9 years:................................34-305 mg/dL 10-11 years: ...........................55-204 mg/dL 12-13 years: ...........................58-359 mg/dL 14-15 years: ...........................47-249 mg/dL 16-19 years: ...........................61-350 mg/dL Adults:.....................................88-410 mg/dL |
| |
| Clinical Utility: |
| Selective IgA deficiency characterized by IgA less than 5 mg/dL with other immunoglobulins normal or increased, is associated with allergies, recurrent sinopulmonary infection, autoimmune disease, and HLAA28, B14 or A1. |
| |
Print |
| Immunoglobulin A Subclasses |
| |
| Includes: |
•IgA, Total •IgA Subclasses 1 and 2 |
| |
| CPT: |
82784, 82787 (x2) |
| |
| Alternate Name: |
IgA Subclasses |
| |
| Methodology: |
Nephelometry |
| |
| Testing Schedule: |
Routine, 1 time per week |
| |
| Report Available: |
7-10 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum |
| |
| Container: |
Gold top (serum separator) tube |
| |
| Special Instructions and/or Comments: |
| Refrigerate |
| |
| Reference Range: |
| Age | IgA1 | IgA2 | Total IgA | | 0-2 | 18-63 | 3-19 | 25-75 | | 3-6 | 25-126 | 2-31 | 31-153 | | 7-12 | 49-183 | 3-43 | 56-232 | | >12 | 54-296 | 10-96 | 79-399 |
|
| |
Print |
| Immunoglobulin D |
| |
| CPT: |
82784 |
| |
| Alternate Name: |
IgD |
| |
| Methodology: |
Nephelometry |
| |
| Testing Schedule: |
Routine, daily |
| |
| Report Available: |
2-4 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum |
| |
| Container: |
Gold top (serum separator) tube |
| |
| Special Instructions and/or Comments: |
| Refrigerate |
| |
| Reference Range: |
| <=10 mg/dL |
| |
| Clinical Utility: |
Useful for, Quantitative determination of the immunoglobulins can provide important information onthe humoral immune status.Changes in IgD concentration are used as a marker ofchanges in the size of the clone of monoclonal IgD plasma cells. |
| |
Print |
| Immunoglobulin E, Total |
| |
| CPT: |
82785 |
| |
| Alternate Name: |
IgE; Quantitative IgE; Total IgE |
| |
| Methodology: |
Rate Nephelometry |
| |
| Testing Schedule: |
Routine, 3 times per week |
| |
| Report Available: |
3-5 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
Pediatrics:..........0.4 mL serum Adults:...............1 mL serum |
| |
| Container: |
Gold top (serum separator) tube OR 2 yellow or red BD Microtainer™ tubes |
| |
| Reference Range: |
•<1 year:..............................<15 IU/mL •1-5 years:...........................<60 IU/mL •6-9 years:...........................<90 IU/mL •10-15 years:.......................<200 IU/mL •16 years to adult:...............<100 IU/mL |
| |
| Clinical Utility: |
| Immunoglobulin E (IgE) is firmly bound to mast cells and only trace amounts are normally present in serum. When antigen (allergen) cross-links two IgE molecules,the mast cell is stimulated to release histamine and other vasoactive amines. These vasoactive amines are responsible for the vascular permeability and smooth muscle contraction occurring in such allergic reactions as hay fever, asthma, urticaria, and eczema. |
| |
Print |
| ImmunoglobulinG |
| |
| CPT: |
82784 |
| |
| Alternate Name: |
IgG; Quantitative IgG |
| |
| Methodology: |
Rate Nephelometry |
| |
| Testing Schedule: |
Routine, daily |
| |
| Report Available: |
1-3 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
Pediatrics:...............0.4 mL serum Adults:....................1 mL serum |
| |
| Container: |
Gold top (serum separator) tube OR 2 yellow or red BD Microtainer™ tubes |
| |
| Reference Range: |
•0-1 year........................232-1411 mg/dL •1-3 years......................453-916 mg/dL •4-6 years......................504-1465 mg/dL •7-9 years......................572-1474 mg/dL •10-11 years..................698-1560 mg/dL •12-13 years:................759-1550 mg/dL •14-15 years.................716-1711 mg/dL •16-19 years.................549-1584 mg/dL •Adults........................690-1400 mg/dL |
| |
Print |
| Immunoglobulin G Subclasses |
| |
| Includes: |
•IgG, Total •IgG Subclasses 1, 2, 3 and 4 |
| |
| CPT: |
82784, 82787 (x4) |
| |
| Alternate Name: |
IgG Subclasses |
| |
| Methodology: |
Nephelometry |
| |
| Testing Schedule: |
Routine, daily |
| |
| Report Available: |
2-4 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum |
| |
| Container: |
Gold top (serum separator) tube |
| |
| Special Instructions and/or Comments: |
| Refrigerate |
| |
| Reference Range: |
| See report. |
| |
| Clinical Utility: |
| Assess humoral immunity. Immunoglobulin G (IgG) isthe most abundant immunoglobulin of extravascularliquids (65%) and of serum (70-75%). Antibodies of theIgG class are produced in response to most bacteria and viruses. |
| |
Print |
| Immunoglobulin G/A/M |
| |
| See Immunoglobulin Profile 1 |
Print |
| Immunoglobulin |
| |
| CPT: |
82784 |
| |
| Alternate Name: |
IgM; Quantitative IgM |
| |
| Methodology: |
Rate Nephelometry |
| |
| Testing Schedule: |
Routine, daily |
| |
| Report Available: |
1-3 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
Pediatrics: 0.4 mL serum Adults: 1 mL serum |
| |
| Container: |
Gold top (serum separator) tube OR 2 yellow or redBD Microtainer™ tubes |
| |
| Reference Range: |
•0-1 year...........................0-145 mg/dL •1-3 years.........................19-146 mg/dL •4-6 years.........................24-210 mg/dL •7-9 years.........................31-208 mg/dL •10-11 years.....................31-180 mg/dL •12-13 years.....................35-239 mg/dL •14-15 years.....................15-188 mg/dL •16-19 years.....................23-259 mg/dL •Adults.............................34-210 mg/dL |
| |
| Clinical Utility: |
| Immunoglobulin M (IgM) is the most primitive andleast specialized immunoglobulin and the only one thata neonate synthesizes. In adult serum, it accounts for 5to 10% of the total circulating immunoglobulins. It isnot transported across the placenta and is an efficientcomplement activator. |
| |
Print |
| Immunoglobulin Profile 1 |
| |
| Includes: |
•IgG •IgA •IgM |
| |
| CPT: |
82784 (x3): |
| |
| Alternate Name: |
IgG/A/M; Immunodiffusion; Immunoglobulin G/A/M; Quantitative Immunoglobulins; Serum Immunoglobulins |
| |
| Methodology: |
See individual test listings. |
| |
| Testing Schedule: |
Routine, daily |
| |
| Report Available: |
1-3 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
Pediatrics:...........................0.4 mL serum Adults:................................1 mL serum |
| |
| Container: |
Gold top (serum separator) tube OR 2 yellow or red BD Microtainer™ tubes |
| |
| Reference Range: |
| See individual test listings. |
| |
| Clinical Utility: |
| See individual test listings. |
| |
Print |
| Immunoglobulin Profile 2 |
| |
| Includes: |
•IgG •IgA •IgM •IgE |
| |
| CPT: |
82784 (x3), 82785 |
| |
| Alternate Name: |
IgG/A/M/E; Immunodiffusion; Quantitative Immunoglobulins; Serum Immunoglobulins |
| |
| Methodology: |
See individual test listings. |
| |
| Testing Schedule: |
Routine, daily |
| |
| Report Available: |
3-5 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
Pediatrics:....................0.4 mL serum Adults:.........................1 mL serum |
| |
| Container: |
Gold top (serum separator) tube OR 2 yellow or red BD Microtainer™ tubes |
| |
| Reference Range: |
| See individual test listings. |
| |
| Clinical Utility: |
| See individual test listings. |
| |
Print |
| Immunohistochemistry |
| |
| See Histopathology, Immunoperoxidase Procedures |
Print |
| Inderal® |
| |
| See Propranolol |
Print |
| India Ink Preparation |
| |
| CPT: |
87210 |
| |
| Alternate Name: |
Cerebrospinal Fluid India InkPreparation; Cryptococcus Preparation See Also:Cryptococcal Antigen |
| |
| Methodology: |
India Ink |
| |
| Testing Schedule: |
Routine; STAT testing available |
| |
| Report Available: |
1 day |
| |
| Specimen Requirements: |
| Minimum Volume: |
5 mL cerebrospinal fluid |
| |
| Container: |
Sterile conical tube |
| |
| Collection: |
The specimen can be divided for fungal culture,mycobacteria culture and smear; routine bacterialculture and Gram stain only if the specimen isaccompanied by properly completed requisitionsand if the specimen is of adequate volume for alltestsrequested. |
| |
| Special Instructions and/or Comments: |
•Transport to the laboratory immediately. •Maintain specimen at room temperature. •DO NOT centrifuge, aliquot, refrigerate orfreeze. Reference Range:India Ink negative, noencapsulated yeast seen. |
| |
| Clinical Utility: |
Cryptococcosis is a systemic infection caused byCryptococcus neoformans.The organism initiallycauses a pulmonary infection which is often subclinicalbut rapidly disseminates and shows a predilection forthe central nervous system. |
| |
Print |
| Indican, Urine |
| |
| CPT: |
81005 |
| |
| Methodology: |
Colorimetry |
| |
| Testing Schedule: |
Routine, Monday-Friday only |
| |
| Report Available: |
<5 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
10 mL random urine |
| |
| Container: |
Plastic urine container |
| |
| Collection: |
Freshly voided random urine |
| |
| Special Instructions and/or Comments: |
| •Transport to the laboratory immediately. |
| |
| Reference Range: |
| Negative |
| |
| Clinical Utility: |
| The amount of indican normally excreted in the urine issmall. However, large amounts are produced as a resultof high protein diets and in various disorders such as Hartnup disease, intestinal obstruction, gastric cancer,hypochlorhydria, biliary obstruction, and malabsorptive conditions such as sprue and blind-loop syndrome. |
| |
Print |
| Indirect Antiglobulin Test |
| |
| See Type and Antibody Screen |
Print |
| Indirect Anti-Human Globulin Test |
| |
| See Type and Antibody Screen |
Print |
| Indirect Coombs |
| |
| See Type and Antibody Screen |
Print |
| Infectious Mononucleosis Screening Test |
| |
| See Mononucleosis ScreenInfluenza A/B Antibody |
| See Influenza A/B Antibody Profile |
Print |
| Influenza A/B Antibody Profile |
| |
| Includes: |
IgG and IgM antibodies to both Influenza A and B |
| |
| CPT: |
86710 X 4 |
| |
| Alternate Name: |
Influenza A/B Antibody; Influenza A/B Titer; Influenza Antibodies |
| |
| Methodology: |
Indirect Fluorescent Antibody (IFA) |
| |
| Testing Schedule: |
Routine, Monday-Friday ONLY |
| |
| Report Available: |
2-4 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
2 mL serum |
| |
| Container: |
Gold top (serum separator) tube |
| |
| Special Instructions and/or Comments: |
| Refrigerate |
| |
| Reference Range: |
| <1:10 for both IgG and IgM |
| |
| Clinical Utility: |
| Determination of recent infection when isolation of theorganism by culture is unsuccessful. |
| |
Print |
| Influenza A/B Screen, Rapid |
| |
| Includes: |
NOTE: Rapid influenza screen is only done in season. •Screen for Influenza A and B •Reflexed when negative to Respiratory virus culture •Enhanced shell vial cell culture/immunofluorescent stain for Influenza A/B, RSV, Adenovirus,Parainfluenza 1, 2, 3 |
| |
| CPT: |
87804 (x2), Reflexed when appropriate:87254 x7 |
| |
| Alternate Name: |
Rapid, Flu A/B Screen |
| |
| Methodology: |
Rapid Enzmye Immunoassay (EIA) |
| |
| Testing Schedule: |
Routine, daily |
| |
| Report Available: |
•2 hours from receipt of specimen for RapidScreen •1-3 days for Culture, Immunfluorescent Stain |
| |
| Specimen Requirements: |
| Minimum Volume: |
•Nasal aspirate OR nasal washings •Swabs of nasopharyngeal |
| |
| Container: |
Viral culture kit |
| |
| Collection: |
NOTE: Kit (obtained from laboratory) is provided with “flocked” swab and a viral transport tube (UTM). Nasopharyngeal swab is specimen of choice (Also acceptable : nasal secretions in viral transport media or nasal wash collected in saline) •To collect Nasopharyngeal swab - Gently pass the swab through the nose and into the posterior nasopharynx. Rub the swab on the nasopharyngeal membrane several times to loosen and collect cellular material. Withdraw swab and place swab in UTM-RT tube and snap off at the score mark. Securely screw on cap of UTM. Label tube with patient name + collection date. •Complete HNL Lab Requisition Form •Order FLUAB for rapid Flu testing (negative Rapid Flu is reflexed to a full respiratory virus culture unless request states DO NOT CULTURE) •Send to Laboratory on wet ice |
| |
| Special Instructions and/or Comments: |
| NOTE: All negative Rapid Influenza A/B AntigenScreens are followed up by a virus culture.Please indicate if follow up culture is NOT wanted. |
| |
| Reference Range: |
| Influenza is seasonal viral diasease usually occurring in the winter months typical symptomsare fever, chills ,myalgia. Differentiation of Influenza A and B is important for treatment options. If the rapid screen is negative the specimen is reflexed to culture for seven respiratory pathogens (Influenza A and B, RSV,Adenovirus, Parainfluenza 1,2,and 3)using mixed celllines and immunoflourescent staining Rapid diagnosis of respiratory viral infections is important for the proper treatment of patients and to prevent the needless use of antbiotics or antiviral drugs. |
| |
Print |
| Influenza A/B Serum, Rapid |
| |
| See Influenza A/B Antibody Profile |
Print |
| Influenza A/B Titer |
| |
| See Influenza A/B Antibody Profile |
Print |
| Influenza Antibodies |
| |
| See Influenza A/B Antibody Profile |
Print |
| Influenza Virus Culture |
| |
| See Culture, Viral, Respiratory |
Print |
| Inorganic Phosphate, Blood |
| |
| See Phosphorus, Serum |
Print |
| Insulin Antibody |
| |
| CPT: |
86337 |
| |
| Methodology: |
Radioimmunoassay (RIA) |
| |
| Testing Schedule: |
Routine, 3 times per week |
| |
| Report Available: |
5-7 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum |
| |
| Container: |
Gold top (serum separator) tube |
| |
| Special Instructions and/or Comments: |
•Centrifuge, transfer to plastic aliquot tube and refrigerate. |
| |
| Reference Range: |
| < 0.02 nmol/L |
| |
| Clinical Utility: |
Useful for: 1. Predicting the future development of type 1 diabetes in asymptomatic children, adolescents and young adults, when used in conjunction with family history, HLA typing, and other autoantibodies such as Glutamic Acid Decarboxylase (GADAB) Antibody. 2.Differential diagnoses of type 1 vs type 2 diabetes. 3. Evaluating diabetes with insulin resistance. |
| |
Print |
| Insulin-Like Growth Factor |
| |
| CPT: |
84305 |
| |
| Alternate Name: |
IGF-1; Somatomedin-C |
| |
| Methodology: |
Automated Immunochemilumenometric Assay (ICMA) |
| |
| Testing Schedule: |
Routine, daily |
| |
| Report Available: |
5-7 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum |
| |
| Container: |
Gold top (serum separator) tube |
| |
| Special Instructions and/or Comments: |
| Centrifuge specimen, transfer serum to plastic aliquot tube and refrigerate. |
| |
| Reference Range: |
| < 1 year | Not established | | 1 year | 55-327 ng/mL | | 2 years | 51-303 ng/mL | | 3 years | 49-289 ng/mL | | 4 years | 49-283 ng/mL | | 5 years | 50-286 ng/mL | | 6 years | 52-297 ng/mL | | 7 years | 57-316 ng/mL | | 8 years | 64-345 ng/mL | | 9 years | 74-388 ng/mL | | 10 years | 88-452 ng/mL | | 11 years | 111-551 ng/mL | | 12 years | 143-693 ng/mL | | 13 years | 183-850 ng/mL | | 14 years | 220-972 ng/mL | | 15 years | 237-996 ng/mL | | 16 years | 226-903 ng/mL | | 17 years | 193-731 ng/mL | | 18 years | 163-584 ng/mL | | 19 years | 141-483 ng/mL | | 20 years | 127-424 ng/mL | | 21-25 years | 116-358 ng/mL | | 26-30 years | 117-329 ng/mL | | 31-35 years | 115-307 ng/mL | | 36-40 years | 109-284 ng/mL | | 41-45 years | 101-267 ng/mL | | 46-50 years | 94-252 ng/mL | | 51-55 years | 87-238 ng/mL | | 56-60 years | 81-225 ng/mL | | 61-65 years | 75-212 ng/mL | | 66-70 years | 69-200 ng/mL | | 71-75 years | 64-188 ng/mL | | 76-80 years | 59-177 ng/mL | | > 81 years | 55-166 ng/mL |
|
| |
| Clinical Utility: |
Useful for: • Diagnosing growth disorders • Diagnosing adult growth deficiency • Monitoring of rhGH treatment • Diagnosis and follow-up of acromegaly and gigantism as part of laboratory monitoring of nutritional status. |
| |
Print |
| Insulin Like Growth Factor BP3 |
| |
| CPT: |
83520 |
| |
| Alternate Name: |
IGFBP-3, Insulin-Like Growith Factor Binding Protein 3 |
| |
| Methodology: |
Enzyme-labeled Chemiluminescent Immunometric Assay |
| |
| Testing Schedule: |
Routine, daily |
| |
| Report Available: |
3-5 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum (Minimum spec: 0.3mL) |
| |
| Container: |
Gold top (serum separator) tube |
| |
| Special Instructions and/or Comments: |
| Refrigerate |
| |
| Reference Range: |
| Accompanies report |
| |
| Clinical Utility: |
Useful for: • Diagnosing growth disorders • Diagnosing adult GH-deficiency • Monitoring of rhGH treatment |
| |
Print |
| Insulin, Serum |
| |
| CPT: |
83525 |
| |
| Methodology: |
Chemiluminescent Immunoassay |
| |
| Testing Schedule: |
Routine, 2 times per week STAT testing available 0600-2100 |
| |
| Report Available: |
2-4 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum |
| |
| Container: |
Gold top (serum separator) tube |
| |
| Collection: |
Overnight fast preferred. |
| |
| Special Instructions and/or Comments: |
•Testing must be performed within 8 hours ofcollection. •If delay in transport, centrifuge transfer to plasticaliquot tube and refrigerate tube in the uprightposition.Specimen should remain capped untiltime of testing. •EDTA plasma is unacceptable. •Avoid markedly hemolyzed, icteric or lipemicspecimens. |
| |
| Reference Range: |
| <29.2 uIU/mL |
| |
| Clinical Utility: |
| Evaluate insulin producing neoplasm (islet cell tumor,insulinoma) or pancreatic islet cell hyperplasia; work-upfor hypoglycemia to evaluate insulin production indiabetes mellitus. Insulin-secreting tumors usuallypresent with hypoglycemic symptoms and are diagnosed by a 72-hour prolonged fast. After 72 hours of fasting aninsulin concentration greater than 6 mU/L indicates aninsulinoma. Factitious hypoglycemia from exogenousinsulin shows increased insulin, but not proinsulin or C-peptide. |
| |
Print |
| Intact Parathyroid Hormone |
| |
| See Parathyroid Hormone, Intact, Serum |
Print |
| Intact Parathyroid Hormone Profile |
| |
| See Parathyroid Hormone, Intact, Profile |
Print |
| Intact PTH |
| |
| See Parathyroid Hormone, Intact, Serum |
Print |
| Intercellular Antibody Basement Membrane Antibody |
| |
| See Histopathology, Skin Biopsy, Immunofluorescence |
Print |
| Interstitial Cell Stimulating Hormone |
| |
| See Luteinizing Hormone, Serum |
Print |
| Intraoperative Consultation |
| |
| See Histopathology, Frozen Tissue Section |
Print |
| Intravascular Coagulation Screen |
| |
| See Disseminated Intravascular Coagulation Profile |
Print |
| Intravenous Catheter Tip Culture |
| |
| See Culture, Catheter Tip |
Print |
| Intrinsic Factor Blocking Autoantibody |
| |
| CPT: |
86340 |
| |
| Methodology: |
Competitive binding immunoenzymatic assay |
| |
| Testing Schedule: |
Routine, daily |
| |
| Report Available: |
3-5 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum |
| |
| Container: |
Gold top (serum separator) tube |
| |
| Collection: |
This test should not be ordered on patients who have received a vitamin B(12) injection within the last 2 weeks. |
| |
| Special Instructions and/or Comments: |
| • Refrigerate |
| |
| Reference Range: |
| Negative |
| |
| Clinical Utility: |
| Useful For: Confirming the diagnosis of pernicious anemia |
| |
Print |
| Iodine, Serum |
| |
| CPT: |
83789 |
| |
| Methodology: |
Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) |
| |
| Testing Schedule: |
Routine, Mon.-Fri. ONLY |
| |
| Report Available: |
5-7 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum |
| |
| Container: |
Royal Blue top trace metal tube, red label |
| |
| Special Instructions and/or Comments: |
•Centrifuge, pour serum into metal free, acid washed vial and refrigerate • DO NOT insert pipette into serum to accomplish transfer. • DO NOT ream the specimen with a wooden stick. • Specimen will only be accepted in vials labeled with “metal free” labels |
| |
| Reference Range: |
| 40-92 ng/mL |
| |
| Clinical Utility: |
Useful for: •Determination of Iodine overload. •Monitoring iodine levels in individuals taking iodine containing drugs (such as amiodarone). |
| |
Print |
| Iodine, 24 hr Urine |
| |
| CPT: |
83789 |
| |
| Methodology: |
Inductibely Coupled Plasma-Mass Spectrometry (ICP-MS) |
| |
| Testing Schedule: |
Routine, Mon.-Fri. ONLY |
| |
| Report Available: |
3-5 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
10 mL Aliquot of a well mixed 24 hour urine |
| |
| Container: |
24 hour plastic urine container, no preservative 5 mL of 50% acetic acid added at start of collection also acceptable as preservative. Plastic Urine container for random specimens |
| |
| Collection: |
1. If this test is used in conjunction with the (131)I uptake test, then specimen collection should begin immediately after the dose of (131)I is given (ie, the patient should void and discard urine just prior to the (131)I, and all subsequent urine should be collected for the nent 24 hours). The last void should be inculded in the collection. 2. High concentrations of gadolinium are known to interfere with most metals tests. If gadolinium-containing contrast media has been administered, a specimen cannot be collected for 48 hours. |
| |
| Special Instructions and/or Comments: |
• Instruct the patient to void at the beginning of collection period and discard the specimen. • Collect all urine including the final specimen voided at the end of the collection period. • Refrigerate during collection. |
| |
| Reference Range: |
Iodine Concentration:................42-350 mcg/L Iodine, 24 hour concentration:.....100-460 mcg/specimen |
| |
| Clinical Utility: |
| Useful for monitoring iodine excretion rate as an index of daily iodine replacement therapy. Correlating total body iodine load with (131)I uptake studies in assessing thyroid function. |
| |
Print |
| Ionic Calcium |
| |
| See Calcium, Ionized, Whole Blood |
Print |
| Ionized Calcium |
| |
| See Calcium, Ionized, Whole Blood |
Print |
| Iontophoresis |
| |
| See Chloride, Sweat |
Print |
| Iron, Serum |
| |
| CPT: |
83540 |
| |
| Alternate Name: |
Fe, Serum |
| |
| Methodology: |
Endpoint |
| |
| Testing Schedule: |
Routine, STAT testing available |
| |
| Report Available: |
1 day |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum |
| |
| Container: |
Gold top (serum separator) tube |
| |
| Special Instructions and/or Comments: |
Overnight fast preferred. •A first morning specimen is preferred due to diurnal variation. •Collect specimen prior to patient receiving iron therapy or blood transfusion. •If patient has undergone a blood transfusion,delay testing for several days. |
| |
| Reference Range: |
| 40-170 µg/dL |
| |
| Clinical Utility: |
| Used to evaluate anemias and iron overload. |
| |
Print |
| Irregular Antibodies |
| |
| See Type and Antibody Screen |
Print |
| Islet Cell Antibody |
| |
| See Islet Cell Autoantibody |
Print |
| Islet Cell Autoantibody |
| |
| CPT: |
86341 |
| |
| Alternate Name: |
Anti-Islet Cell Antibody; Islet Cell Antibody |
| |
| Methodology: |
Indirect Fluorescent Antibody (IFA) |
| |
| Testing Schedule: |
Routine, 2 time per week |
| |
| Report Available: |
5-7 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum |
| |
| Container: |
Gold top (serum separator) tube |
| |
| Special Instructions and/or Comments: |
| Refrigerate |
| |
| Reference Range: |
| <1:2 |
| |
| Clinical Utility: |
| Differentiates insulin-dependent diabetes from noninsulin-dependent diabetes. |
| |
Print |
| Isoagglutinin Titer, Anti-A and/or Anti-B |
| |
| Includes: |
•ABO •Rh (D) •Titer |
| |
| CPT: |
86900, 86901, 86941 |
| |
| Alternate Name: |
Anti-A Titer; Anti-B Titer; Isohemagglutinins |
| |
| Methodology: |
Hemagglutination |
| |
| Testing Schedule: |
Routine, daily |
| |
| Report Available: |
1-3 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
4 mL plasma |
| |
| Container: |
Pink top (EDTA) tube |
| |
| Special Instructions and/or Comments: |
| •Non-hospitalized patients: Submit specimen with a completed Blood Bank Requisition (LAB-04)Form. |
| |
| Reference Range: |
•No agglutination: Normal agglutination titer not observed. •Agglutination: Normal agglutination, titer observed and reported. •Normal adult titer:......................... >=16 |
| |
| Clinical Utility: |
The following blood types indicate expectedisoagglutinin (anti-A and/or anti-B): •AB: not present •A: anti-B •B: anti-A •O: anti-A, B, ; anti-A: anti-B |
| |
Print |
| Isohemagglutinins |
| |
| See Isoagglutinin Titer, Anti-A and/or Anti-B |
Print |
| Isopora |
| |
| See Ova and Parasite, Stool |
Print |
| Isoptin® |
| |
| See Verapamil |
Print |
| I.V. Catheter Tip |
| |
| See Culture, Catheter Tip |
Print |
| I.V. Tubing Culture |
| |
| See Culture, Catheter Tip |
Print |
| Ivy Bleeding Time |
| |
| See Bleeding Time, Template |
|